case_images: PMC11324202_01
case_images: a Endoscopic biopsies of the pancreatic mass showed infiltrating neoplastic glands within hyalinized stroma as well as clusters of irregular duct-like structures with marked nuclear pleomorphism, diagnostic of moderately differentiated PDAC. b Extensive sampling of the pancreaticoduodenectomy (Whipple) specimen showed no evidence of residual PDAC but instead broad areas of fibrosis with scattered inflammatory cells and atrophic acinar lobules with islet cell hyperplasia, compatible with treatment effect.
case_images: cro-2024-0017-0001-539776_F01.jpg
case_images: PMC11324202_01_cro-2024-0017-0001-539776_F01.jpg
case_images: F1
case_images: Endoscopic ultrasound revealed a pancreatic tumor, which was positive for pancreatic ductal adenocarcinoma (PDAC) (Fig. 1a). T0N0 (Fig. 1b).
case_images: a Baseline CT scan performed on July 2022 showing a hepatic lesion with rim enhancement measuring 1.9 cm. b CT scan performed a year later on August 2023 showing lesion no longer present.
case_images: cro-2024-0017-0001-539776_F02.jpg
case_images: PMC11324202_01_cro-2024-0017-0001-539776_F02.jpg
case_images: F2
case_images: Her initial computed tomography (CT) scan in July 2022 showed a lesion in the hepatic dome, measuring 1.9 cm, most likely metastatic disease (Fig. 2a). CT scan and PET were performed. CT did not show any evidence of metastatic disease in the liver (Fig. 2b).
case_images: a October 2022 PET/CT scan showing FDG activity of the distal body lesion. b Repeat PET/CT June 2023 PET/CT scan showing activity of the pancreatic body lesion. The interim PET/CT scan showed no change.
case_images: cro-2024-0017-0001-539776_F03.jpg
case_images: PMC11324202_01_cro-2024-0017-0001-539776_F03.jpg
case_images: F3
case_images: An initial PET scan performed in October 2022 demonstrated intense FDG activity in the distal body of the pancreas (Fig. 3a). PET showed normal uptake throughout the pancreas without evidence of metastatic disease in the chest, abdomen, or pelvis (Fig. 3b).